16 pending office actions • 11 clients
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 18426858 | MOUNTING PANEL FOR A VERTICAL GARDEN, VERTICAL GARDEN SYSTEM WITH FOLDABLE PANELS, AND MOUNTING AND DISMOUNTING METHODS THEREOF | Unknown | CALLAWAY, SPENCER THOMAS | 3642 | Final Rejection | Jan 30, 2024 |
| 18580322 | BUDESONIDE 21-PHOSPHATE SODIUM SALT FOR USE AS ANTI-INFLAMMATORY OR ANTIASTHMATIC AGENT | Genetic S.p.A. | SZNAIDMAN, MARCOS L | 1628 | Non-Final OA | Jan 18, 2024 |
| 18579645 | PROCESS FOR THE PREPARATION OF BUDESONIDE 21-PHOSPHATE | Genetic S.p.A. | PIHONAK, SARAH | 1627 | Non-Final OA | Jan 16, 2024 |
| 18555103 | A COMBINATION COMPRISING A SPECIFIC HDAC6 INHIBITOR AND AT LEAST ONE CTLA4 CHECKPOINT INHIBITOR | Italfarmaco Spa | CHHAY, BONIRATH | 1645 | Non-Final OA | Oct 12, 2023 |
| 18554511 | TREATMENT OF NEUROPATHIC CORNEAL PAIN WITH NGF | Tufts Medical Center, Inc. | FISCHER, JOSEPH | 1658 | Non-Final OA | Oct 09, 2023 |
| 18551033 | NEW PROCESS FOR THE SYNTHESIS OF 5-{5-CHLORO-2-[(3S)-3-[(MORPHOLIN-4-YL)METHYL]-3,4-DIHYDROISOQUINOLINE-2(1H)- CARBONYL]PHENYL}-1,2-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID DERIVATIVES AND ITS APPLICATION FOR THE PRODUCTION OF PHARMACEUTICAL COMPOUNDS | Novartis AG | SEAMAN, D MARGARET M | 1625 | Non-Final OA | Sep 18, 2023 |
| 18548231 | MACROCYCLIC LRRK2 KINASE INHIBITORS | Oncodesign Precision Medicine (Opm) | RAO, PADMAJA S | 1627 | Non-Final OA | Aug 29, 2023 |
| 18317386 | ATTENUATED POXVIRUS VECTOR BASED VACCINE FOR PROTECTION AGAINST COVID-19 | Sementis Limited | SALVOZA, M FRANCO G | 1672 | Final Rejection | May 15, 2023 |
| 18040708 | NOVEL OXADIAZOLE-BASED SELECTIVE HDAC6 INHIBITORS | Italfarmaco S.p.A. | NOLAN, JASON MICHAEL | 1623 | Final Rejection | Feb 06, 2023 |
| 18007321 | COMBINATION OF A BCL-2 INHIBITOR AND A HYPOMETHYLATING AGENT FOR TREATING CANCERS, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF | Novartis AG | BAUER, NICOLA MARIA | 1621 | Non-Final OA | Jan 30, 2023 |
| 18004468 | DIOSMIN PREPARATION METHOD | Les Laboratoires Servier | LEE, HOI YAN NMN | 1693 | Non-Final OA | Jan 06, 2023 |
| 17968253 | CO-CRYSTALS OF TRAMADOL AND COXIBS | Esteve Pharmaceuticals, S.A. | LEE, WILLIAM Y | 1623 | Non-Final OA | Oct 18, 2022 |
| 17834232 | HIGH FREQUENCY APPLICATION OF BOTULINUM TOXIN THERAPY | Merz Pharma GmbH & Co. Kgaa | HUMPHREY, LOUISE WANG ZHIYING | 1657 | Final Rejection | Jun 07, 2022 |
| 17609452 | USE OF CO-CRYSTALS OF TRAMADOL AND CELECOXIB FOR TREATING PAIN WHILE REDUCING THE ABUSE LIABILITY OF TRAMADOL | Esteve Pharmaceuticals, S.A. | MOORE, SUSANNA | 1624 | Non-Final OA | Nov 08, 2021 |
| 17413973 | RECOMBINANT VECTORS FOR THE LONG TERM TREATMENT OF MUCCHOPOLYSACHARIDOSIS | UNIVERSITA AUTÒNOMA DE BARCELONA | TRAN, CHRISTINA L | 1637 | Final Rejection | Jun 15, 2021 |
| 17336491 | COMPOSITIONS COMPRISING TRAMADOL AND CELECOXIB IN THE TREATMENT OF PAIN | Esteve Pharmaceuticals, S.A. | ORWIG, KEVIN S | 3991 | Non-Final OA | Jun 02, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial